Vernon Hills, IL, United States of America

Kevin C Spence

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kevin C. Spence: Innovator in Pharmaceutical Formulations

Introduction

Kevin C. Spence, an esteemed inventor based in Vernon Hills, IL, has made significant contributions to the field of pharmaceutical formulations. With a focus on addressing women's health issues, his innovation has the potential to impact many lives.

Latest Patents

Kevin holds a noteworthy patent related to pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome, or adenomyosis. The patent details innovative pharmaceutical compositions that comprise a gonadotropin-releasing hormone (GnRH) antagonist. Additionally, it encompasses methods for preparing and utilizing these compositions, including techniques for facilitating the release of the GnRH antagonist from the formulations.

Career Highlights

Throughout his career, Kevin has worked with prominent companies such as AbbVie Inc. and Neurocrine Biosciences, Inc. His experiences in these organizations have likely shaped his understanding of pharmaceutical needs and advanced his skills as an inventor.

Collaborations

Kevin has collaborated with talented professionals throughout his career, including Jayanthy Jayanth and Gregory A. McClelland. These partnerships highlight his commitment to innovation and the collaborative nature of research in the pharmaceutical industry.

Conclusion

Kevin C. Spence exemplifies the role of an inventor who is dedicated to improving women's health through innovative pharmaceutical solutions. His patent achievements and collaborations shed light on the dynamic world of medical innovations, showcasing the vital contributions of inventors in enhancing healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…